Nightstar Expands Pipeline with Novel Gene Therapy for the Treatment of Stargardt Disease – GlobeNewswire (press release)
|
Nightstar Expands Pipeline with Novel Gene Therapy for the Treatment of Stargardt Disease
GlobeNewswire (press release) LEXINGTON, Mass. and LONDON, Nov. 08, 2017 (GLOBE NEWSWIRE) — Nightstar Therapeutics (NASDAQ:NITE), a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, today announced an expansion of its pipeline … |
